Invalda AB received notification (attached) about transactions on the issuer’s securities, completed by the executive officer. Kristina GudauskaiteAssistant to President+370 52752776
MoreInvalda AB and other Sanitas AB shareholders, all together controlling 87,2% shares, on 19 August 2011, have finished the sale this shareholding in AB Sanitas to Valeant Pharmaceuticals International, Inc…
MoreInvalda AB received notifications (attached) about the executive officers’ and persons’ associated with them completed transactions on the issuer’s securities:Darius Sulnis Lucrum Investicija UAB
MoreInvalda AB received notification (attached) about transactions on the issuer’s securities, completed by the persons’ associated with executive officer. Kristina GudauskaiteAssistant to President+370 52752776
MorePreliminary results of Invalda AB group for 3 months of 2011:– consolidated profit before taxes equals to 8.43 mln. LTL (2.44 mln. EUR);– part of consolidated profit attributable to shareholders..
MoreInvalda AB received notifications (attached) about the executive officers’ and persons’ associated with them completed transactions on the issuer’s securities:Darius Sulnis Lucrum Investicija UAB Kristina GudauskaiteAssistant to President+370 52752776
MoreAB Invalda and other AB Sanitas shareholders, all together controlling 87,2% shares, on 23 May 2011, have signed a definitive share sale and purchase agreement for the sale of their..
MoreInvalda AB received notifications (attached) about the executive officers’ and persons’ associated with them completed transactions on the issuer’s securities:Darius Sulnis Lucrum Investicija UAB Kristina GudauskaiteAssistant to President+370 52752776
MoreThe resolutions of the Ordinary General Shareholders meeting that was held on 29 April, 2011: 1. Got acquainted with the Auditor‘s report and the report of the Audit Committee. 2…
More